Brain biopsy in dementia: Clinical indications and diagnostic approach

Acta Neuropathologica

Volumn 120, Issue 3, 2010, Pages 327-341

  Schott, Jonathan M ^a   Reiniger, Lilla ^b   Thom, Maria ^b   Holton, Janice L ^b   Grieve, Joan ^a   Brandner, Sebastian ^b   Warren, Jason D ^a   Revesz, Tamas ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAR DNA BINDING PROTEIN;

ALZHEIMER DISEASE; BRAIN BIOPSY; BRAIN VASCULITIS; CLINICAL ASSESSMENT; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; GLIOSIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; LABORATORY DIAGNOSIS; MEDICAL DECISION MAKING; NEUROPATHOLOGY; NEUROSURGERY; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEFECT; REVIEW; SEIZURE; SURGICAL APPROACH; TAUOPATHY; VASCULAR AMYLOIDOSIS;

ALGORITHMS; BIOPSY; BRAIN; DEMENTIA; HUMANS;

EID: 77956225516     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-010-0721-y     Document Type: Review

References (60)

1. A Al-Araji DP Kidd 2009 Neuro-Behcet's disease: epidemiology, clinical characteristics, and management Lancet Neurol 8 192 204 10.1016/S1474-4422(09) 70015-8 19161910
2. M Ball H Braak P Coleman, et al. 1997 Consensus recommendations for the postmortem diagnosis of Alzheimer's disease Neurobiol Aging 18 S1 S2 10.1016/S0197-4580(97)00052-3
3. Basu N, WATTS R, Bajema I et al (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis (Epub ahead of print)
4. J Birnbaum DB Hellmann 2009 Primary angiitis of the central nervous system Arch Neurol 66 704 709 10.1001/archneurol.2009.76 19506130
5. K Blennow H Zetterberg 2009 Cerebrospinal fluid biomarkers for Alzheimer's disease J Alzheimers Dis 18 413 417 1:CAS:528:DC%2BD1MXht1CjsrfF 19661632
6. H Brunnstrom M Dictor C Nilsson D Gulich E Englund 2009 A 76-year-old man with cognitive and neurological symptoms Brain Pathol 19 731 734 10.1111/j.1750-3639.2009.00311.x 19744045
7. NJ Cairns EH Bigio IR Mackenzie, et al. 2007 Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration Acta Neuropathol 114 5 22 10.1007/s00401-007-0237-2 17579875
8. NJ Cairns V Zhukareva K Uryu, et al. 2004 Alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease Am J Pathol 164 2153 2161 1:CAS:528:DC%2BD2cXltFymsb4%3D 15161649
9. S Capellari C Vital P Parchi, et al. 1997 Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family Neurology 49 133 141 1:CAS:528:DyaK2sXkvFemsrg%3D 9222181
10. RJ Caselli BF Boeve BW Scheithauer JD O'Duffy GG Hunder 1999 Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy Neurology 53 1579 1581 1:STN:280:DC%2BD3c%2FgtFyguw%3D%3D 10534272
11. R de Silva T Lashley G Gibb, et al. 2003 Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies Neuropathol Appl Neurobiol 29 288 302 10.1046/j.1365-2990.2003.00463. x 12787326
12. DW Dickson H Fujishiro C Orr, et al. 2009 Neuropathology of non-motor features of Parkinson disease Parkinsonism Relat Disord 15 Suppl 3 S1 S5 10.1016/S1353-8020(09)70769-2 20082965
13. MS Dulai CY Park WD Howell, et al. 2008 CNS T-cell lymphoma: an under-recognized entity? Acta Neuropathol 115 345 356 10.1007/s00401-007-0338-y 18196250
14. GF Duna LH Calabrese 1995 Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system J Rheumatol 22 662 667 1:STN:280:DyaK2MzhtFamtw%3D%3D 7791160
15. Duna GF, Calabrese LH (2005) Primary angiitis of the central nervous system. In: Kalimo H (ed) Cerebrovascular diseases. ISN Neuropath Press, Basel, pp 147-150
16. MM Esiri J Carter JW Ironside 2000 Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases Neuropathol Appl Neurobiol 26 273 284 10.1046/j.1365-2990.2000.00239.x 1:CAS:528:DC%2BD3cXltVOrsrk%3D 10886685
17. MD Geschwind H Shu A Haman JJ Sejvar BL Miller 2008 Rapidly progressive dementia Ann Neurol 64 97 108 10.1002/ana.21430 18668637
18. F Graus A Saiz J Dalmau 2010 Antibodies and neuronal autoimmune disorders of the CNS J Neurol 257 509 517 10.1007/s00415-009-5431-9 1:CAS:528: DC%2BC3cXktFOjuro%3D 20035430
19. F Graus A Saiz M Lai, et al. 2008 Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations Neurology 71 930 936 10.1212/01.wnl.0000325917.48466.55 1:CAS:528:DC%2BD1cXhtVygurvM 18794496
20. JA Hainfellner P Parchi T Kitamoto C Jarius P Gambetti H Budka 1999 A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein Ann Neurol 45 812 816 10.1002/1531-8249(199906)45:6<812::AID- ANA20>3.0.CO;2-2 1:STN:280:DyaK1M3oslGhsQ%3D%3D 10360778
21. RL Hamilton 2000 Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry Brain Pathol 10 378 384 10.1111/j.1750-3639.2000.tb00269.x 1:STN:280:DC%2BD3cvotFWktw%3D%3D 10885656
22. PA Hayward JE Bell JW Ironside 1994 Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease Neuropathol Appl Neurobiol 20 375 383 10.1111/j.1365-2990.1994.tb00983.x 1:STN:280:DyaK2M7gslClsQ%3D%3D 7808588
23. CA Heath SA Cooper K Murray, et al. 2010 Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease Ann Neurol 67 761 770 10.1001/archneurol.2010.116 20517937
24. M Ikemura Y Saito R Sengoku, et al. 2008 Lewy body pathology involves cutaneous nerves J Neuropathol Exp Neurol 67 945 953 10.1097/NEN. 0b013e318186de48 18800013
25. SR Irani K Bera P Waters, et al. 2010 N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes Brain 133 1655 1667 10.1093/brain/awq113 20511282
26. KA Josephs JL Holton MN Rossor, et al. 2003 Neurofilament inclusion body disease: a new proteinopathy? Brain 126 2291 2303 10.1093/brain/awg231 12876145
27. KA Josephs FA Rubino DW Dickson 2004 Nonvasculitic autoimmune inflammatory meningoencephalitis Neuropathology 24 149 152 10.1111/j.1440-1789. 2004.00542.x 15139593
28. KA Josephs JL Whitwell DS Knopman, et al. 2008 Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype Neurology 70 1850 1857 10.1212/01.wnl.0000304041.09418.b1 1:CAS:528: DC%2BD1cXhtFags7jE 18401022
29. SA Josephson AM Papanastassiou MS Berger, et al. 2007 The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia J Neurosurg 106 72 75 10.3171/jns.2007.106. 1.72 17236490
30. JJ Kepes DG Malone W Griffin LA Moral WL Yarde S Jones 1995 Surgical "touch artefacts" of the cerebral cortex. An experimental study with light and electron microscopic analysis Clin Neuropathol 14 86 92 1:STN:280:DyaK2MzjtV2nsQ%3D%3D 7606902
31. PL Lantos NJ Cairns MN Khan, et al. 2002 Neuropathologic variation in frontotemporal dementia due to the intronic tau 10(+16) mutation Neurology 58 1169 1175 1:CAS:528:DC%2BD38XjslSrsL0%3D 11971082
32. Lashley T, Ahmed Z, Borroni B et al (2010) FUS pathology in frontotemporal lobar degenerations. Neuropathol Appl Neurobiol 36(Suppl 1):15
33. T Lashley JL Holton E Gray, et al. 2008 Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients Acta Neuropathol 115 417 425 10.1007/s00401-007-0336-0 1:CAS:528:DC%2BD1cXjsFGisL4%3D 18185940
34. C Lucantoni BP De F Doglietto, et al. 2009 Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review J Neurooncol 94 235 242 10.1007/s11060-009-9834-3 19322520
35. RG Macfarlane SJ Wroe J Collinge TA Yousry HR Jager 2007 Neuroimaging findings in human prion disease J Neurol Neurosurg Psychiatry 78 664 670 10.1136/jnnp.2006.094821 1:STN:280:DC%2BD2szlsV2quw%3D%3D 17135459
36. IR Mackenzie M Neumann EH Bigio, et al. 2010 Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update Acta Neuropathol 119 1 4 10.1007/s00401-009-0612-2 19924424
37. IR Mackenzie M Neumann EH Bigio, et al. 2009 Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations Acta Neuropathol 117 15 18 10.1007/s00401-008-0460-5 19015862
38. L Massey T Lashley SS O'Sullivan, et al. 2008 TDP-43 proteinopathy in progressive supranuclear palsy (PSP) Mov Disord 23 100
39. H Nakashima-Yasuda K Uryu J Robinson, et al. 2007 Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases Acta Neuropathol (Berl) 114 221 229 10.1007/s00401-007-0261-2 1:CAS:528:DC%2BD2sXosFKrsLs%3D
40. M Neumann R Rademakers S Roeber M Baker HA Kretzschmar IR Mackenzie 2009 A new subtype of frontotemporal lobar degeneration with FUS pathology Brain 132 2922 2931 10.1093/brain/awp214 19674978
41. M Neumann S Roeber HA Kretzschmar R Rademakers M Baker IR Mackenzie 2009 Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease Acta Neuropathol 118 605 616 10.1007/s00401-009-0581-5 1:CAS:528:DC%2BD1MXhtlKitLrE 19669651
42. M Neumann DM Sampathu LK Kwong, et al. 2006 Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 130 133 10.1126/science.1134108 1:CAS:528:DC%2BD28XhtVCiurrL 17023659
43. Paisan-Ruiz C, Li A, schneider s, et al. (2010) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging (in press)
44. LA Pfeifer LR White GW Ross H Petrovitch LJ Launer 2002 Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study Neurology 58 1629 1634 1:STN:280:DC%2BD38zhsFWnsw%3D%3D 12058090
45. O Pletnikova N West MK Lee, et al. 2005 Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases Neurobiol Aging 26 1183 1192 10.1016/j.neurobiolaging.2004.10.006 1:CAS:528: DC%2BD2MXks1CntLs%3D 15917102
46. M Ponzoni AJ Ferreri 2006 Intravascular lymphoma: a neoplasm of 'homeless' lymphocytes? Hematol Oncol 24 105 112 10.1002/hon.776 16721900
47. Reiniger L, Lukic A, Linehan J et al (2010) Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol (Epub ahead of print)
48. T Revesz JL Holton T Lashley, et al. 2009 Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies Acta Neuropathol 118 115 130 10.1007/s00401-009-0501-8 1:CAS:528:DC%2BD1MXmt1ahu7Y%3D 19225789
49. C Salvarani RD Brown Jr KT Calamia, et al. 2007 Primary central nervous system vasculitis: analysis of 101 patients Ann Neurol 62 442 451 10.1002/ana.21226 17924545
50. NJ Scolding 2009 Central nervous system vasculitis Semin Immunopathol 31 527 536 10.1007/s00281-009-0183-2 19908043
51. NJ Scolding F Joseph PA Kirby, et al. 2005 Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy Brain 128 500 515 10.1093/brain/awh379 15659428
52. EE Smith SM Greenberg 2009 Beta-amyloid, blood vessels, and brain function Stroke 40 2601 2606 10.1161/STROKEAHA.108.536839 1:CAS:528: DC%2BD1MXnsFyjtbY%3D 19443808
53. GK Tofaris T Revesz TS Jacques S Papacostas J Chataway 2007 Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entity Arch Neurol 64 280 282 10.1001/archneur.64.2.280 17296847
54. H Uchikado WL Lin MW DeLucia DW Dickson 2006 Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy J Neuropathol Exp Neurol 65 685 697 10.1097/01.jnen.0000225908.90052.07 1:CAS:528: DC%2BD28XotFeiu7c%3D 16825955
55. K Uryu H Nakashima-Yasuda MS Forman, et al. 2008 Concomitant TAR-DNA-Binding Protein 43 Pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies J Neuropathol Exp Neurol 67 555 564 10.1097/NEN.0b013e31817713b5 1:CAS:528:DC%2BD1cXotVant7g%3D 18520774
56. B Van Everbroeck J Boons P Cras 2005 Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease Clin Neurol Neurosurg 107 355 360 10.1016/j.clineuro. 2004.12.002 16023527
57. Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5:16 (Epub ahead of print)
58. A Vincent C Buckley JM Schott, et al. 2004 Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis Brain 127 701 712 10.1093/brain/awh077 14960497
59. JD Wadsworth C Powell JA Beck, et al. 2008 Molecular diagnosis of human prion disease Methods Mol Biol 459 197 227 10.1007/978-1-59745-234-2-14 1:CAS:528:DC%2BD1cXosVSqtLg%3D 18576157
60. JD Warren JM Schott NC Fox, et al. 2005 Brain biopsy in dementia Brain 128 2016 2025 10.1093/brain/awh543 1:STN:280:DC%2BD2MvmtFGrtA%3D%3D 15901648